ECHA calls for comments on etridiazole's reproductive toxicity and carcinogenicity

23-May-2013 - Finland

The proposal for harmonised classification and labelling (CLH) of etridiazole was submitted by the Netherlands in February 2012 and was already subject to a public consultation which ended on 13 April 2012.

After the closure of that public consultation, concerns have been raised by the Committee for Risk Assessment (RAC) regarding reproductive toxicity. In particular, the relevance of the data on malformations and maternal toxicity induced by etridiazole for CLH is of special concern.

In addition, the interpretation of data concerning the carcinogenic potential of etridiazole is under RAC discussion. As carcinogenicity and reproductive toxicity were not specifically addressed in the list of hazard classes for which comments were requested during the previous public consultation and to strengthen the information base, in this exceptional case ECHA would like to provide the parties concerned with a second opportunity to comment on these hazard classes.

Other news from the department politics & laws

Most read news

More news from our other portals

Is artificial intelligence revolutionising chemistry?